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previous GWAS on height based on analysis of individual 
SNPs. A replication analysis in 4080 Australians of Euro-
pean ancestry confirmed the significant CH-like association 
at 9p24.3 (P < 0.05). Together, the collapsed genotypes at 
these six loci explained 2.51% of the height variance (after 
adjusting for sex and age), compared with 3.23% explained 
by the 14 top-associated SNPs at 14 loci identified by tradi-
tional GWAS in the same data set (P < 5 × 10−8). Overall, 
our study empirically demonstrates that CH plays an impor-
tant role in adult height and may explain a proportion of its 
“missing heritability”. Moreover, our findings raise promis-
ing expectations for other highly polygenic complex traits 
to explain missing heritability identifiable through CH-like 
associations.
Introduction
Human adult height is highly influenced by genetic factors 
with an estimated heritability of up to 80% (Carmichael and 
McGue 1995; Nielen et al. 2001; Silventoinen et al. 2003, 
2008). A number of large-scale GWASs (Estrada et al. 2009; 
Abstract Adult height is the most widely genetically 
studied common trait in humans; however, the trait vari-
ance explainable by currently known height-associated sin-
gle nucleotide polymorphisms (SNPs) identified from the 
previous genome-wide association studies (GWAS) is yet 
far from complete given the high heritability of this complex 
trait. To exam if compound heterozygotes (CH) may explain 
extra height variance, we conducted a genome-wide analysis 
to screen for CH in association with adult height in 10,631 
Dutch Europeans enriched with extremely tall people, using 
our recently developed method implemented in the software 
package CollapsABEL. The analysis identified six regions 
(3q23, 5q35.1, 6p21.31, 6p21.33, 7q21.2, and 9p24.3), 
where multiple pairs of SNPs as CH showed genome-wide 
significant association with height (P < 1.67 × 10−10). Of 
those, 9p24.3 represents a novel region influencing adult 
height, whereas the others have been highlighted in the 
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Liu et al. 2014; Wood et al. 2014; Yang et al. 2010), carried 
out to explore the genetic architecture underlying the vari-
ation in height, have successfully identified at close to 700 
common single nucleotide polymorphisms (SNPs) (Wood 
et al. 2014), and more recently 83 low-frequency (Marouli 
et al. 2017) variants, showing genome-wide significant asso-
ciation with height. However, these SNPs together can only 
explain about 21.6% (Marouli et al. 2017) of the phenotypic 
variance in the study populations (combined sample size 
711,428 individuals) due to the extremely small effect sizes 
for most associated SNPs. Large fractions of the “missing 
heritability” are also known to occur in a wide range of 
human complex traits and common disorders (Keller et al. 
2012; Ridge et al. 2013; Tomlinson et al. 2011). Missing 
heritability represents the central challenge in understanding 
the genetics of common traits in humans, with consequences 
for future applications in different fields such as precision 
medicine and forensic genetics.
Aside from epigenetic factors, there are two mutu-
ally compatible leading theories for the major sources of 
this missing heritability. The first theory emphasizes that 
there may exist a large body of rare or low-frequency DNA 
variants, each with moderate-to-large effects (Bodmer and 
Bonilla 2008). Such variants are not detectable due to low 
statistical power, low array coverage, and low imputation 
quality for rare variants (Yang et al. 2015). Consequently, the 
key to solving the “missing heritability” puzzle is to scale 
up sample sizes together with genome-sequencing-based 
techniques, which are both time-consuming and expensive. 
For example, a very recent exome chip study of height car-
ried out by the GIANT Consortium identified 32 extremely 
rare (MAF <0.01) height-associated variants, some with 
much larger effects than previously seen for common SNPs, 
using a data set consisting of 840,552 individuals (Marouli 
et al. 2017). The second theory stresses that variation in 
most quantitative phenotypes must result at least in part from 
multifactorial genetic perturbation of highly dynamic, inter-
connected biochemical networks (Mackay 2014), while the 
traditional association studies focus on additive effects of 
individual genes (Carlborg and Haley 2004; Manolio et al. 
2009). The challenge here is that the abundance of complex 
forms of genetic interactions will be hard to detect due to the 
problem of combinatorial complexity that demands large-
scale computational power.
Compound heterozygotes (CH) in classical genetics refer 
to two different mutations at a particular gene, one on each 
chromosome—both typically rare and deleterious (Schaaf 
et al. 2011), together cause an autosomal recessive trait. CH 
has been found in nearly all autosomal recessive disorders, 
where multiple mutations (i.e., different alleles) can affect 
the function of the gene product and lead to disease (Bezzina 
et al. 2003; Krude et al. 1998; Liu et al. 2011; Whittock 
et al. 2002), and therefore, a common genetic mechanism 
is assumed. Considering that trait-associated DNA vari-
ants identified from GWAS are typically non-coding due 
to the design of the SNP microarrays used, and can thus be 
involved in the regulation of gene expression (Visser et al. 
2012, 2014, 2015), it is reasonable to expect that interactions 
involving non-coding DNA variants can also be highly rele-
vant in the genetics of complex traits. Therefore, we recently 
proposed relaxed forms of CH, in which genetic variants 
physically close to one another [and in linkage disequilib-
rium (LD) to one another] are likely involved in a wide range 
of human polygenic traits and may present an important 
source of the “missing heritability” (Liu et al. 2016; Zhong 
et al. 2016a). Accordingly, we had developed a generalized 
collapsed double heterozygosity (GCDH) test to screen for 
CH-like association in GWASs. This method is implemented 
in the publically available R package CollapsABEL (Zhong 
et al. 2016a). Recently, we demonstrated that this approach 
was able to detect new genetic loci associated with the skin 
condition actinic keratosis via genome-wide GCDH analysis 
(Zhong et al. 2016b).
In the current study, we investigate if CH-like SNP 
interactions are associated with adult height in Europeans, 
and if so, to which extent they contribute to explaining the 
“missing heritability” previously noted for height with the 
conventional GWAS approach. For this, we used CollapsA-
BEL to carry out genome-wide GCDH analysis to previously 
established genome-wide SNP array data of 10,361 Dutch 
Europeans from the Rotterdam Study (RS), including 770 
additional Dutch Europeans of extremely tall stature (Liu 
et al. 2014), and used data from 4080 unrelated individuals 
of European origin from the Queensland Institute of Medical 
Research (QIMR) as a replication data set.
Results
Characteristics of the study populations are listed in 
Online Resource 1. A conventional GWAS in 10,361 
Dutch Europeans from the RS including 770 extremely 
tall Dutch Europeans identified 101 SNPs from 14 loci 
(Fig. 1a and Online Resource 2), showing genome-wide 
significant association with height (P < 5 × 10−8). The 
top-associated SNPs at each locus were rs12485899 from 
3p22.1 (ZNF621, P = 3.50 × 10−9, β = −0.57), rs9838625 
from 3q23 (ZBTB38, P  =  2.71  ×  10−10, β  =  0.62), 
rs1265097 from 6p21.33 (PSORS1C1, P = 5.39 × 10−9, 
β = −0.89), rs2780226 from 6p21.31 (GRM4/HMGA1, 
P  =  4.26  ×  10−8, β  =  0.92), rs7741741 from 6q24.1 
(GPR126, P = 1.72 × 10−8, β = −0.6), rs4272 from 7q21.2 
(CDK6, P = 4.23 × 10−9, β = 0.68), rs6984782 from 8q12.1 
(CHCHD7, P = 1.80 × 10−9, β = −0.94), rs4931222 from 
12p11.22 (TMTC1, P = 3.05 × 10−8, β = −1.36), rs1038196 
from 12q14.3 (HMGA2, P = 3.86 × 10−8, β = −0.53), 
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rs7159961 from 14q11.2 (OR4Q3, P  =  2.68  ×  10−10, 
β  =  −2.66), rs1366870 from 15q11.2 (LOC727924, 
P = 6.67 × 10−11, β = −2.34), rs2279007 from 19p13.11 
(MYO9B, P = 1.65 × 10−8, β = −0.65), rs6060355 from 
20q11.22 (UQCC1, P  =  3.15  ×  10−9, β  =  0.59), and 
rs10439884 from 21p11.1 (TPTE, P  =  3.06  ×  10−9, 
β = −2.16). Among these, two loci (15q11.2 and 21p11.1) 
represent novel findings, but at both loci, the top-associated 
SNPs had relatively low minor allele frequency (MAF, at 
1–2%), while the remaining 12 loci have been previously 
identified by the GIANT Consortium via traditional GWAS 
(Wood et al. 2014). Note that the test statistics from our con-
ventional GWAS slightly deviated from the expected distri-
bution under the null hypothesis of no association (λ = 1.05, 
Fig. 2a). In contrast, the test statistics from a permutation 
analysis (k = 5, Fig. 2a) followed the expected distribution 
under the null tightly, suggesting that the significant sig-
nals are unlikely false positives due to residual population 
substructures.
We then conducted an exact replication analysis of these 
14 SNPs in 4080 unrelated Australian Europeans from the 
Queensland Institute for Medical Research (QIMR). The two 
Fig. 1  Manhattan plots from RS. Minus log of P value is represented 
by blue and red dots and grouped by chromosome. a Manhattan plot 
for single-SNP GWAS. The horizontal line (−log 5 × 10−8) indicates 
threshold of genome-wide significance. b Manhattan plot for GCDH 
scan, the horizontal line (−log 1.67  ×  10−10) indicates threshold of 
GCDH genome-wide significance. Loci are annotated in green if they 
have not been reported before with genome-wide height association 
by the GIANT consortium (Wood et al. 2014)
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novel loci which had very low MAF in QIMR (0.1–0.2%) 
are thus not available for replication. For the remaining 12 
SNPs, 10 showed the same allele effect direction as in the RS 
and 6 showed nominally significant association with height 
(P < 0.05, Online Resource 2), highlighting GRM4/HMGA1, 
GPR126, CDK6, HMGA2, MYO9B, and UQCC1 genes. The 
replication rate of the single SNPs was lower than expected 
from our power analysis, which showed a >90% probability 
of replicating all the 14 SNPs (see Online Resource 3). The 
lower replication rate may be explained by multiple factors. 
For example, allelic heterogeneity has been previously noted 
as a frequent feature underlying the genetic architecture of 
adult (Allen et al. 2010). Notably, the novel loci 15q11.2 
and 21p11.1 did not replicate because of the very low MAF 
(0.1–0.2%) in QIMR.
We conducted a genome-wide screening for relaxed forms 
of compound or double heterozygotes that are potentially 
associated with adult height in the RS. This analysis was 
conducted using our recently developed software package 
CollapsABEL implementing a generalized collapsed double 
heterozygosity test (GCDH). The GCDH employs a gen-
eralized linear modeling framework to test the association 
between a pseudo-marker and a phenotype with or with-
out covariates, where the pseudo-marker is collapsed from 
two physically close SNPs, as described in more details in 
the “Materials and methods”. The test statistics from the 
GCDH genome screening (Fig. 2b) showed a large deviation 
(λ = 4.16) from the expected null of the conventional GWAS 
as the result of multiple testing from the sliding window 
approach implemented in CollapsABEL. This deviation is 
expected, because first, CollapsABEL only reports the most 
significant association signal per window, i.e., a problem of 
multiple testing of correlated SNPs, and second, a p-filter 
was applied to pre-remove SNPs with little or no marginal 
effect. Therefore, we conducted a permutation analysis to 
approximate the null empirically, i.e., repeating the full 
GCDH genome screening five times using permuted phe-
notype values, and considered the distribution of the result-
ant test statistics as an empirical null distribution (Fig. 2b). 
Although the number of permutation is small due to the 
computational burden, it is obvious that the GCDH results 
deviated substantially from the empirical null distribu-
tion, which is unlikely explained by false-positive findings 
(Fig. 2b). This GCDH screen provided genome-wide sig-
nificant evidence for six genetic regions consisting of CH-
like association signals from the collapsed pseudo-markers 
(3q23, 5q35.1, 6p21.31, 6p21.33, 7q21.2, and 9p24.3, 
P < 1.67 × 10−10, see Fig. 1b; Table 1 and Online Resource 
4). Notably, none of the individual SNPs in these regions 
showed genome-wide significant association in our conven-
tional GWAS (P > 5 × 10−8). The top-associated pseudo-
markers were collapsed from SNP pairs in these six regions, 
including rs9821337_rs6762826 from 3q23 (ZBTB38, 
P = 9.59 × 10−11, β = 0.62), rs1466947_rs17070997 from 
5q35.1 (SLIT3, P = 8.21 × 10−11, β = −0.78), rs1776897_
rs2744977 from 6p21.31 (GRM4/HMGA1/C6orf106, 
P = 1.61 × 10−13, β = 0.78), rs6904669_rs1960278 from 
6p21.33 (PSORS1C3/HLA-C, P = 9.32 × 10−14, β = −0.89), 
rs7793983_rs17164894 from 7q21.2 (CDK6/SAMD9, 
P = 3.56 × 10−11, β = 0.87), and rs514779_rs10962274 from 
Fig. 2  QQ plots. a QQ plot of single-SNP P values. b QQ plot of GCDH P values. In both cases, P values from five permutation analyses were 
also plotted to estimate the null distribution
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9p24.3 (DMRT2/SMARCA2, P = 9.34 × 10−11, β = −0.98). 
One of the six loci, 9p24.3 (see also the regional plot, as 
shown in Fig. 3), represents a novel finding, whereas the 
other five (see regional plots in Online Resource 5) had been 
previously described as influencing height variation by the 
GIANT Consortium from a large-scale conventional GWAS 
(Wood et al. 2014). Significant GCDH signals were detected 
at two additional loci, 15q11.2 and 19p13.11, but are poten-
tially explained by strong single-SNP association effects 
rather than the effect of a pair of SNPs, since individual SNP 
analysis already detected those SNPs as genome-wide signif-
icant (rs1366870 and rs2217377 in 15q11.2 and rs11671774, 
rs2279008, and rs2279007 in 19p13.11, see Fig. 1). 
We then conducted an exact replication analysis of these 
six SNP pairs in the QIMR data set. The newly identified 
locus 9p24.3 (rs514779_rs10962274, P = 0.026, β = −0.48) 
as well as three previously known markers were replicated at 
nominal significance, i.e., rs9821337_rs6762826 from 3q23 
(P = 1.49 × 10−8, β = 0.72), rs1776897_rs2744977 from 
6p21.31 (P = 0.0093, β = 0.37), rs17688839_rs17164894 
from 7q21.2 (P = 0.0019, β = 0.44). All of these replicated 
β values showed the same directions as those in the Dutch 
Europeans (Table 1).
A previous large-scale meta-analysis of height GWASs 
identified 697 SNPs at different loci independently contrib-
uting to the variation in adult height and 658 SNPs were 
available in our RS data set. The proportion of sex- and 
age-adjusted height variance explainable by these 658 SNPs 
in our data set was estimated at 19.13% by constructing a 
polygenic risk score based on the weighted allele sums of 
all 658 SNPs (Table 2). This polygenic score is referred to 
below as PRS658. A multivariable analysis further dem-
onstrated that on top of the PRS658, the six top-associated 
pseudo-markers collapsed from six pairs of SNPs explained 
2.51%, and the 14 top-associated SNPs from our conven-
tional GWAS explained 3.23% of the sex- and age-adjusted 
height variance (Table 2). For all six loci, the top-associated 
pseudo-marker explained a substantially higher proportion 
of the trait variance than individual SNPs of a pair, i.e., 
when any of the two SNPs was tested in a univariate model 
(Online Resource 6), and explained a higher or similar pro-
portion of the trait variance than the two SNPs together, 
i.e., when both SNPs were included in a multiple regression 
model (Online Resource 6). This indicates that including the 
pseudo-markers in prediction modeling may not necessarily 
boost the prediction accuracy compared with the models 
including all pairs of SNPs in CH. However, it should be 
emphasized that the use of the pseudo-marker provides a 
substantially higher power in detecting CH-like association 
signals than the conventional GWAS.
Diplotype configuration inference supports the involve-
ment of compound heterozygotes for three of the six pseudo-
markers (3q23, 6p21.33, and 7q21.2) and the involvement of Ta
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Fig. 3  Regional Manhattan plot 
of GCDH P values from 9p24.3
Table 2  Multivariable linear 
model including 14 single 
SNPs, 6 CH SNP pairs and 
the weighted allele sum of 658 
SNPs previously reported to 
be associated with height as 
independent variables
a Total percentage of variation in height explained by 6 CH SNPs
b Total percentage of variation in height explained by 14 single SNPs
c Total percentage of variation in height explained by all independent variables in the model
Variable Cytoband Gene −log10 P R2
PRS658 945.12 19.13
rs10439884 21p11.1 TPTE 19.22 0.32
rs7159961 14q11.2 OR4Q3 17.25 0.33
rs1366870 15q11.2 LOC727924 16.33 0.31
rs2279007 19p13.11 MYO9B 15.53 0.44
rs4931222 12p11.22 TMTC1 13.10 0.29
rs12485899 3p22.1 ZNF621 11.35 0.30
rs4272 7q21.2 CDK6 4.99 0.28
rs6984782 8q12.1 CHCHD7 3.33 0.26
rs7741741 6q24.1 GPR126 3.25 0.30
rs1038196 12q14.3 HMGA2 2.10 0.23
rs9838625 3q23 ZBTB38 1.93 0.12
rs1265097 6p21.33 PSORS1C1 1.89 0.04
rs6060355 20q11.22 UQCC1 1.38 0.01
rs2780226 6p21.31 GRM4 0.90 0.01
rs514779_rs10962274 9p24.3 DMRT2/SMARCA2 19.20 0.39
rs1466947_rs17070997 5q35.1 SLIT3 13.17 0.39
rs7793983_rs17164894 7q21.2 LOC101927497 11.65 0.50
rs6904669_rs1960278 6p21.33 PSORS1C3/HLA-C 10.39 0.48
rs1776897_rs2744977 6p21.31 GRM4/HMGA1 4.02 0.39
rs9821337_rs6762826 3q23 ZBTB38 0.76 0.36
Total  1a 2.51
Total  2b 3.23
Total  3c 24.87
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double (non-compound) heterozygotes (see Online Resource 
7 for an illustration and double and compound heterozygo-
sity) for the other three pseudo-markers (Online Resource 8).
Discussion
An empirical application of the GCDH approach (as imple-
mented in CollapsABEL) to height identified novel CH-like 
interactions and markers that are likely not identifiable by 
the conventional GWAS. With only a small fraction of the 
sample size of the GIANT study (Wood et al. 2014), we 
found CH-like interactions among known height-related 
SNPs and one previously unknown marker, which in turn 
explained a sizable percentage of variance in height. It is, 
therefore, expected that an application of CollapsABEL to 
the full GIANT data set (Wood et al. 2014) will reveal many 
more CH-like interactions which may include novel height 
loci not identifiable via standard single-SNP GWAS.
The two SNPs rs514779 and rs1853417 from the novel 
region 9p24.3 are located between the genes DMRT2 and 
SMARCA2. DMRT2 is a candidate gene for sex determina-
tion and is also involved in development of somites and mus-
cle tissue in the embryo (Ottolenghi et al. 2000; Ounap et al. 
2004; Seo 2007). Both functions may be important in deter-
mining adult height, although DMRT2 has not been reported 
to be associated with height in the literature. SMARCA2 
encodes a protein, that is, part of the ATP-dependent chro-
matin remodeling complex SNF/SWI, which is required 
for transcriptional activation of genes normally repressed 
by chromatin (Koga et al. 2009). The interaction between 
the transcription-regulator gene SMARCA2 and the devel-
opment-related gene DMRT2 makes perfect sense, although 
it needs further functional study to be verified.
The other five loci highlighted via CH-like effects (3q23, 
5q35.1, 6p21.31, 6p21.33, and 7q21.2) have all been previ-
ously identified via large-scale traditional single-SNP GWAS 
of the GIANT Consortium (Wood et al. 2014). However, 
the CH-like interactions of SNPs found here had not been 
reported before. These results indicate that CH-like interac-
tions among known loci may explain a sizable proportion of 
the phenotypic variance. The six best CH SNP pairs chosen 
from each significant locus accounted for 2.51%, compared 
to 3.23% by the 14 single SNPs from RS and 19.13% by 
PRS658. This clearly demonstrates that phenotypic variance 
explained by genetic CH-like interactions can be orthogonal 
to that attributed to single SNPs, a finding for height that is 
expected for other complex traits as well.
Notably, we have used an additive model, i.e., the alter-
native collapsing matrix (Zhong et al. 2016a), for genotype 
collapsing, which does not strictly differentiate between 
compound heterozygosity and non-compound double het-
erozygosity or any form of pairwise interaction between 
two variants showing an additive effect. As a consequence, 
the SNP pairs discovered cannot be expected to be all in 
CH. According to our diplotype inference results (Online 
Resource 8), GCDH signals were confirmed in three (3q23, 
6p21.33, and 7q21.2) of the six most significant pseudo-
markers. This implies that the relaxed form of CH is an 
important mechanism among the possible interaction forms 
conforming to the additive model, although non-compound 
double heterozygosity and possibly other kinds of genetic 
interactions may also play a significant role. Besides the 
additive model, other possible models (collapsing matrices) 
representing more complex/unknown genetic mechanisms 
could be explored in the future, due to the design flexibility 
of CollapsABEL.
Compared to recent large-scale traditional single-SNP 
GWASs for height carried out by the GIANT Consortium, 
consisting of 253,288 (Wood et al. 2014) up to 381,625 
(Marouli et al. 2017) samples, the current study is of rela-
tively small sample size, which limits statistical power. In 
addition, the preprocessing of genotype data with a P value 
filter, which removes all SNPs without a strong enough 
marginal effect, helped reducing computational burden, 
but also constrained the scope of discoverable interactions. 
However, the main goal of our study was to find out if and 
to what extent can the signals detected by CollapsABEL 
explain “missing heritability”. To maximize statistical power 
in identifying novel CH variants, we included a set of 770 
extremely tall individuals in the RS data set. It had been 
shown previously that the effects of height-associated com-
mon DNA variants are consistent with the predicted poly-
genic effects in extremely tall persons (Chan et al. 2011). 
This consistency is the basis for a successful replication in 
the QIMR data set which does not include extremely tall 
subjects. Our previous study (Liu et al. 2014) using the same 
RS data also confirmed that the genetics of tall stature is 
similar to that of normal height in humans, i.e., heritabil-
ity is for a large part explained by many common variants 
with small effects and allelic heterogeneity is a frequent 
feature, where CH represents a common form of allelic 
heterogeneity.
In comparing the replication results from single-SNP 
and GCDH approaches, we found that pseudo-markers col-
lapsed from pairs of SNPs had a higher replication rate than 
did individual SNPs (50% of the loci were replicated for 
pseudo-markers vs. 35% for individual SNPs). This can be 
explained by the much stricter genome-wide significance 
threshold used in GCDH, i.e., the fewer false positives lead 
to higher reproducibility.
Although our method provides a higher power to detect 
CH-like associations, it cannot pinpoint causal variants 
as does in the conventional GWAS, particularly when the 
associated SNPs are intergenic. Therefore, our method can-
not distinguish between two variants that affect the same or 
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different genes and the finding at DMRT2 and SMARCA2 
requires further functional studies.
Overall, the GCDH approach seems to be sitting at the 
saddle point of the two leading theories for “missing her-
itability”: it can detect CH-like interactions between pairs 
of SNPs often less frequent than what is detectable by the 
conventional GWAS. For future applications with larger 
sample sizes and adequate computing power in combina-
tion with whole genome-sequencing-based techniques, we 
expect GCDH to explain a considerably larger percentage of 
the variance, thus providing a partial explanation for “miss-
ing heritability” and new insights into genetics of human 
complex traits and diseases.
Materials and methods
The Rotterdam Study
The Rotterdam Study (RS) is a prospective population-
based data set study of 14,926 participants’ aged 45 years 
and older, living in a suburb of Rotterdam, The Nether-
lands. Details of the study design and population have been 
described elsewhere (Hofman et al. 2015). The RS has been 
approved by the Medical Ethics Committee of the Erasmus 
MC and by the Ministry of Health, Welfare and Sport of The 
Netherlands, implementing the Wet Bevolkingsonderzoek: 
ERGO (Population Studies Act: Rotterdam Study). All par-
ticipants provided written informed consent to participate in 
the study and to obtain information from their treating physi-
cians. The RS was conducted according to the Declaration 
of Helsinki Principles.
Whole blood DNA extraction, genotyping, quality con-
trols, and 1000 Genome (Consortium 2012)-based geno-
type imputation have been described in detail previously 
(Kreiner-Moller et al. 2015). In brief, genotyping was car-
ried out using the Infinium II HumanHap550 BeadChips 
version 3 (Illumina, San Diego, California USA) and 
Human610-Quad BeadChips. After all quality controls, the 
current study included a total of 2,543,887 autosomal SNPs 
(MAF >0.01, imputation R2 > 0.3, SNP call rate >0.95, 
and HWE >1 × 10−3) in 10,631 individuals. Height was 
measured using a stadiometer (SECA225; SECA, Hamburg, 
Germany). We also included 770 extremely tall subject from 
the Dutch Tall cohort (DT), which used the following inclu-
sion criteria: (1) standard deviation score (SDs) above 1.88 
according to Dutch standards (http://www.tno.nl/groei), 
which corresponds to the 3% upper tail of the height distri-
bution in Dutch adults, approximately >195 cm in men and 
>180 cm in women at age 30, after correcting for secular 
trend, and (2) Dutch European ancestry defined as being 
born to Dutch parents who themselves were born in The 
Netherlands.
The Queensland Institute of Medical Research (QIMR) 
study
The QIMR study comprised 8672 individuals from pre-
dominantly population and family-based studies, around 
4161 from nuclear families living in or near Brisbane, Aus-
tralia, with twins aged around 12–14 years at recruitment for 
clinical studies, and the remainder from older twin families 
across Australia recruited through the Australian Twin Reg-
istry. Genotyping was a subset of an existing larger data set 
which used Illumina SNP array chips in large batches from 
two chip families. Per-batch QC removed SNPs with any of 
(1) MAF <1%; (2) call rate <95%; (3) HWE P value <10−6; 
(4) mean GenCall score <0.7; (5) fail GenomeStudio filters 
as per Illumina QC SOPs; and (6) blacklists based on poor 
retest consistency and mapping issues, particularly gender-
specific heterozygosity and call-rate filters for chromosome 
X. Genotyping of the 8672 was divided between first-
generation Illumina chips (5960 of which 4300 were from 
610 K-quad or (rarely) 660 K-quad chips; 1660 from 370 K 
or 317 K chips), and newer Omni and Core + Exome Illu-
mina chips (2712 of which 2279 were from Core + Exome 
or PsychArray chips; 364 from Omni-2.5; 69 from Omni-
Express). Imputation was to the 1000 Genomes Phase 3 
mixed-population panel via the University of Michigan’s 
Imputation Server in March–April 2015, as one run per 
chromosome for each of the two chip families above, in 
each case for the observed markers available post-QC across 
all batches for that chip family (277,690 markers for first 
generation and 240,297 markers for Omni/Core + Exome); 
the two families merged post-imputation with a binary ‘run 
number’ covariate in the analysis to mitigate differences in 
imputation quality. The current study included 4080 unre-
lated QIMR subjects for replication of the associated SNPs.
GCDH genome screening
We conducted a genome-wide GCDH screening of adult 
height for finding CH-like association in the RS using Col-
lapsABEL. Important parameters of CollapsABEL include 
the collapsing matrix, the window size, and the p-filter. The 
collapsing matrix is constructed according to the underly-
ing genetic model, and defines the way that the two SNPs 
under investigation are collapsed. Assuming a joint recessive 
model for the minor alleles of two nearby SNPs, one may 
choose the default collapsing matrix, based on which the 
two SNPs is collapsed into a pseudo-marker consisting of 
two possible pseudo-genotypes (0 or 1 minor allele vs. 2 or 
more minor alleles). Alternative collapsing matrices may be 
of choice when different genetic models are assumed. In the 
present application of height, we assumed a joint additive 
effect of the minor alleles of two nearby SNPs and thus used 
an alternative collapsing matrix, based on which the two 
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SNPs under investigation are collapsed into a pseudo-marker 
consisting of three possible pseudo-genotypes (0, 1, and 2 or 
more minor alleles). The difference between compound and 
double heterozygotes is illustrated in Online Resource 7. It is 
important to note that compound and double heterozygotes 
are collapsed into the same pseudo-genotype and thus were 
not differentiated during the genome screening stage, but 
were differentiated in the subsequent analysis of the associ-
ated regions, where the haplotypes were inferred based on 
the expectation–maximization algorithm as implemented in 
the haplo.em function of the R package haplo.stats (Schaid 
et al. 2002). When results from haplo.stats show that the CH 
group has higher/lower mean height compared to the group 
with reference alleles in the same direction as β values from 
GCDH analysis, we consider it as a validation of the CH 
model. In the absence of CH group, we consider it an indica-
tion of involvement of other genetic mechanisms.
The genotype collapsing is done for all pairs of nearby 
SNPs within a sliding window which slides over the whole 
genome with one SNP per step. The size of the sliding win-
dow is defined by two criteria, the number of the maximal 
SNPs (k) and the maximal distance (d) between the index 
SNP and its pairing SNP. For each window, the first SNP is 
considered as the index SNP and all the remaining pairing 
SNPs satisfying both criteria are iteratively collapsed with 
the index SNP and all collapsed pseudo-markers are itera-
tively tested for association with the phenotype. Therefore, 
the maximal number of tests per window is k. The mini-
mal P value within each window is assigned to the index 
SNP. In the current study of height, we used k = 300 and 
d = 500 kbp, and reported all pairs of SNPs with P val-
ues smaller than 1.67 × 10−10 (i.e., 5 × 10−8/300) from our 
GCDH genome screening, i.e., Bonferroni correction of the 
maximal possible number of tests per window.
The p-filter defines the inclusion criteria for SNPs with a 
minimal marginal effect in the conventional GWAS. In the 
current study, we set p-filter = 0.1 to achieve the balance 
between SNP coverage and the affordable computational 
burden.
The null distribution of the test statistics from CollapsA-
BEL is expected to be highly inflated, because first, the 
program only reports the most significant association signal 
per window, i.e., a problem of multiple testing of correlated 
SNPs, and second, a p-filter was applied to pre-remove SNPs 
with little or no marginal effect. Since it was difficult to 
derive the null mathematically, we conducted a permuta-
tion analysis to approximate the null empirically. The whole 
GCDH genome screening procedure was performed five 
times using identical parameters, where the genotype–phe-
notype relationship was broken by randomly shuffling the 
order of individuals in the phenotype file (height, sex, age, 
and four PCs) and the resulting test statistics are displayed 
in QQ plots to illustrate the data-specific null distribution of 
our GCDH scan for adult height in the RS.
The conventional GWAS for adult height was conducted 
using PLINK v1.9 assuming an additive allele effect and 
considering sex, age, and four top genome PCs from the 
MDS analysis as covariates. Regional Manhattan plots were 
generated using Locuszoom (Pruim et al. 2010). Power anal-
ysis for the QIMR data set was conducted using the pwr R 
package (Champely 2013), assuming that R2 is consistent 
across RS and QIMR for all the SNPs tested.
Multivariable and replication analyses
A previous large-scale meta-analysis of height GWASs iden-
tified 697 SNPs at different loci independently contributing 
to the variation in adult height and 658 SNPs was available 
in our RS data set. We estimated the proportion of sex- and 
age-adjusted height variance explainable by these 658 SNPs 
in our data set by constructing a polygenic risk score based 
on the weighted allele sums of all 658 SNPs. This polygenic 
score is referred to below as PRS658. We then accessed the 
independent effects of PRS658, the SNPs showing genome-
wide significant association with height in our conventional 
GWAS, and the pseudo-markers showing genome-wide sig-
nificant association with height in our GCDH genome screen 
using a multivariable linear model. More specifically, this 
model considered sex- and age-regressed height residuals 
as the dependent variable and included PRS658, the 14 top-
associated SNPs from our conventional GWAS, and the 6 
top-associated pseudo-markers collapsed from six pairs of 
SNPs from the GCDH genome screen as the explanatory 
variables. The multivariable analysis was conducted in an 
iterative manner to access the R2 change due to individual 
factors using R scripting, i.e., by adding one independ-
ent variable at a time to a linear model in ascending order 
according to the P values from the multivariable analysis 
including all independent variables; the R2 estimated for the 
added independent variable then becomes the R2 difference 
between the current model and a previous model. To fur-
ther compare the height variance explained by the collapsed 
pseudo-markers and by the individual SNPs, we used sex- 
and age-adjusted residuals as the dependent variable and the 
collapsed pseudo-marker as the explanatory variable, which 
is compared with the model using the two individual SNPs 
of the pair as the explanatory variables.
We conducted a replication analysis for the 14 top-asso-
ciated SNPs (one SNP per associated region) from the con-
ventional GWAS and the six top-associated pseudo-markers 
(one per region) from the GCDH genome screen in 4080 
unrelated QIMR subjects using linear regression adjusted 
for sex and age. P values smaller than 0.05 were considered 
as significant replication.
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